Investigators reported practice patterns and clinical outcomes of second-line therapies in patients with primary refractory metastatic renal cell carcinoma (RCC).

Clinicians and their patients with chronic kidney disease (CKD) need to be aware of zinc intake and anemia status.

The Food and Drug Administration has approved Harliku (nitisinone) for the reduction of urine homogentisic acid in adult patients with alkaptonuria.

The telehealth-administered Geriatric Assessment–Guided Intervention (GAIN-S) improves physical function, mood, quality of life, and prognostic understanding among older patients with metastatic ...

Concurrent hypertension and type 2 diabetes elevated mortality risks more than either condition alone among adults in the US.

Total adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function.

The email was sent to top NIH officials who oversee grants to outside researchers — including those at universities and medical centers across the country.